SPDR S&P Biotech ETF $XBI Stock Position Lessened by Whalen Wealth Management Inc.

Whalen Wealth Management Inc. trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 67.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,610 shares of the exchange traded fund’s stock after selling 7,439 shares during the period. Whalen Wealth Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $569,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of XBI. Axiom Investment Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at $26,000. Financial Life Planners purchased a new stake in SPDR S&P Biotech ETF during the 1st quarter worth about $27,000. Angeles Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF in the 2nd quarter valued at about $28,000. SHP Wealth Management acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at about $31,000. Finally, Morling Financial Advisors LLC purchased a new position in SPDR S&P Biotech ETF in the 2nd quarter valued at about $36,000.

SPDR S&P Biotech ETF Trading Down 1.1%

Shares of SPDR S&P Biotech ETF stock traded down $1.64 during mid-day trading on Thursday, hitting $148.59. 8,206,471 shares of the stock were exchanged, compared to its average volume of 9,121,728. The stock has a market capitalization of $9.71 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a twelve month low of $103.43 and a twelve month high of $169.89. The company has a 50-day simple moving average of $158.50 and a 200 day simple moving average of $145.70.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.